尿激酶溶栓治疗发病2h内急性ST段抬高型心肌梗死的疗效被引量：2

Curative Effects of Urokinase Thrombolysis for STEMI on the Onset within 2h

下载PDF

导出

摘要目的研究急性ST段抬高型心肌梗死（STEMI）患者在发病的2 h内采用尿激酶溶栓的疗效。方法选取72例2013年2月~2014年2月接收的STEMI患者,依据发病时间的不同分为对照组和研究组,溶栓后2 h内,研究组较对照组的临床再通率明显要高,复合终点事件的总发生率明显低于对照组（P〈0.05）,具有统计意义。结论发病在2 h内的STEMI患者采取尿激酶溶栓治疗,可明显提高患者的血管再通率,病死率较低,值得推广。 Objective To study the curative effects of urokinase thrombolysis for patients with STEMI on the onset within 2 h.Methods 72 patients with STEMI treated from February 2013 to February 2014 in our hospital were selected and divided into control group and research group according to the duration of disease.The recanalization rate of research group was significantly higher than that of control group; the total incidence of composite endpoint was significantly lower than that of control group（P〈0.05）.Conclusions The treatment of urokinase thrombolysis for patients with STEMI on the onset within 2 h can significantly improve the recanalization rate and reduce the fatality rate.It is worthy of clinical promotion.

作者盛祖桃吕云高彦

机构地区云南省圣约翰医院心内科

出处《航空航天医学杂志》 2015年第4期437-438,共2页 Journal of Aerospace medicine

关键词尿激酶溶栓 STEMI 2 H Urokinase Thrombolysis STEMI 2h

分类号 R542.22 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献5

1覃学美,曹保卫,覃自强.氯吡格雷联合阿司匹林和尿激酶治疗急性ST段抬高型心肌梗死的临床疗效研究[J].中国全科医学,2010,13(8):808-809. 被引量：61
2张纪梅.尿激酶溶栓治疗发病2h内急性ST段抬高型心肌梗死的疗效[J].中国老年学杂志,2013,33(1):170-171. 被引量：53
3张代荣,刘宏.尿激酶联合左旋精氨酸治疗急性ST段抬高型心肌梗死的疗效及安全性观察[J].临床心血管病杂志,2010,26(11):811-813. 被引量：23
4谢后田,程仁力,孙彤.瑞替普酶与尿激酶在急性ST段抬高型心肌梗死溶栓治疗中的比较[J].蚌埠医学院学报,2014,39(9):1244-1245. 被引量：13
5陈德春,王虹艳,曲鹏,刘珍竹.阿托伐他汀对急性ST段抬高型心肌梗死患者尿激酶溶栓疗效的影响[J].中国心血管杂志,2013,18(1):33-36. 被引量：39

二级参考文献27

1Sabatine MS, Cannon CP, Gibson CM, et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST - segment elevation [J]. N Engl J Med, 2005, 352 (12) : 1179-1189.
2Antman EM, Smith SC, Mpert JS, et al. ACC/AHA guidelines for the management of patients with ST - elevation myocardial infarction - executive summary [J]. Circulation, 2004, 110:588 -636.
3Bhatt D, Topol E. Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high - risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial [ J]. Am Heart J, 2004, 148 (2): 263-268.
4COMMIT (CIOpidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group. Early intravenous then oral metoprolol in 45852 patients with acute muocardial infarction : randomised placebo - controlled trial [J]. Lancet, 2005, 366 (17): 1607-1632.
5HIGUCHI K,ABE S,MATSUOKA T,et al.Usefulness of rapid quantitative cardiac troponin T and myoglobin assays for the diagnosis of acute myocardial infarction[J].J Cardiol,2003,41:55-62.
6OZ E,ARSAKAY G.Role of the nitric oxide pathway on ischemia reperfusion injury in an isolated perfused guinea pig heart[J].Gen Pharmacol,2000,34:3-7.
7MOENS A L,CLAEYS M J,TIZNMERMANS J P,et al.Myocardial ischemia/reperfusion-injury.A clinical view on a complex pathophysiological process[J].Int J Cardiol,2005,100:179-190.
8高润霖,吴宁,胡大一,等.心血管病治疗指南和建议[M].北京:人民军医出版社,2005:261-315
9中华医学会心血管病学分会,中华心血管病杂志编辑委员会.急性ST段抬高性心肌梗死诊断和治疗指南.中华心血管病杂志,2010,38:675-687.
10Gregory G, Anders G, Michael D, et al. Effects of arorvastarin on early recurrent is chemic evenly in acute coronary syndromes the MIRACL study: a randomized controlled trial. JAMA, 2001, 285 : 1711-1718.